+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 50 Pages
  • May 2022
  • GlobalData
  • Nevro Corp
  • ID: 4278827
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • NeuSpera Medical Inc
  • Saluda Medical Pty Ltd
  • Stimwave Technologies Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions
  • Corporate strategy - Analyst’s summarization of the company’s business strategy
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
  • Company history - Progression of key events associated with the company
  • Major products and services - A list of major products, services and brands of the company
  • Key competitors - A list of key competitors to the company
  • Key employees - A list of the key executives of the company
  • Executive biographies - A brief summary of the executives’ employment history
  • Key operational heads - A list of personnel heading key departments/functions
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history

Highlights


Nevro Corp (Nevro) is a medical device company, which is engaged in developing novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacological neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treatment related to painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp Key Recent Developments

  • Apr 06, 2022: Nevro to Report First Quarter 2022 Financial Results
  • Mar 07, 2022: Nevro announces positive Medicare coverage update from Noridian for the treatment of painful diabetic neuropathy
  • Dec 21, 2021: Nevro announces settlement of IP litigation with Nalu Medical
  • Oct 11, 2021: Nevro to Report Third Quarter 2021 Financial Results
  • Aug 31, 2021: Nevro Announces Director Appointment

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs

Note: Some sections may be missing if data is unavailable for the company

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Medtronic Plc
  • NeuSpera Medical Inc
  • Saluda Medical Pty Ltd
  • Stimwave Technologies Inc

Section 1 - About the Company
  • Nevro Corp - Key Facts
  • Nevro Corp - Key Employees
  • Nevro Corp - Key Employee Biographies
  • Nevro Corp - Major Products and Services
  • Nevro Corp - History
  • Nevro Corp - Company Statement
  • Nevro Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 – Company Analysis
  • Company Overview
  • Nevro Corp - Business Description
  • Geographical Segment: International
  • Target Markets
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Nevro Corp - Corporate Strategy
  • Nevro Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Nevro Corp - Strengths
  • Nevro Corp - Weaknesses
  • Nevro Corp - Opportunities
  • Nevro Corp - Threats
  • Nevro Corp - Key Competitors

Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Nevro Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Nevro Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Nevro Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments
  • Apr 06, 2022: Nevro to Report First Quarter 2022 Financial Results
  • Mar 07, 2022: Nevro announces positive Medicare coverage update from Noridian for the treatment of painful diabetic neuropathy
  • Oct 11, 2021: Nevro to Report Third Quarter 2021 Financial Results
  • Aug 31, 2021: Nevro Announces Director Appointment
  • Aug 26, 2021: Nevro to Present at Baird 2021 Global Healthcare Conference
  • Jun 22, 2021: Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting
  • May 05, 2021: Nevro Reports First Quarter 2021 Financial Results and Updates 2021
  • Apr 13, 2021: Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
  • Feb 24, 2021: Nevro reports fourth quarter and full year 2020 financial results
  • Feb 01, 2021: Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference

Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • Nevro Corp, Key Facts
  • Nevro Corp, Key Employees
  • Nevro Corp, Key Employee Biographies
  • Nevro Corp, Major Products and Services
  • Nevro Corp, History
  • Nevro Corp, Subsidiaries
  • Nevro Corp, Key Competitors
  • Nevro Corp, Ratios based on current share price
  • Nevro Corp, Annual Ratios
  • Nevro Corp, Interim Ratios
  • Nevro Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Nevro Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022
  • Nevro Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Nevro Corp, Performance Chart (2017 - 2021)
  • Nevro Corp, Ratio Charts
  • Nevro Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022
  • Nevro Corp, Medical Equipment, Deals by Type, 2016 to YTD 2022

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Stimwave Technologies Inc
  • Saluda Medical Pty Ltd
  • NeuSpera Medical Inc
  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories